Press release
Moderate to Severe Psoriasis Market is projected to reach USD 47.68 billion by 2034
Moderate to Severe Psoriasis
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71343
Moderate to severe psoriasis affects approximately 20-30% of the global psoriasis population and typically requires systemic therapies, phototherapy, or biologic interventions. These patients experience higher rates of psoriatic arthritis, cardiovascular disease, obesity, depression, and metabolic disorders, which supports strong therapy demand across the long-term treatment cycle.
Key Market Highlights
• 2024 Market Size: USD 24.73 billion
• 2034 Forecast: USD 47.68 billion
• CAGR (2025-2034): 6.8%
• Largest Therapy Class: IL-17 and IL-23 inhibitors
• Fastest-Growing Segment: JAK inhibitors & next-generation biologics
Epidemiology & Patient Population Insights
1. Global Psoriasis Prevalence
• ~125 million people have psoriasis worldwide.
• Moderate to severe forms affect 25-35 million individuals.
2. Disease Severity Definition
Moderate to severe psoriasis typically includes:
• PASI score: ≥10
• BSA involvement: >10%
• DLQI: major quality-of-life impairment
3. Major Comorbidities
Moderate to severe patients have increased risk of:
• Psoriatic arthritis
• Cardiovascular disease
• Type 2 diabetes
• Hypertension
• Depression and anxiety
• Nonalcoholic fatty liver disease
These comorbidities increase systemic therapy utilization.
Market Growth Drivers
1. Exceptional Adoption of Biologics
Leading biologic classes driving growth:
• IL-17 inhibitors
• IL-23 inhibitors
• TNF inhibitors
These agents offer rapid, durable skin clearance with strong safety profiles.
2. Rising Use of Oral Targeted Therapies
PDE4 inhibitors and JAK inhibitors are increasingly used for patients who prefer oral therapy or do not qualify for injectables.
3. Expanding Psoriatic Arthritis (PsA) Co-diagnosis
Up to 30% of psoriasis patients develop PsA, boosting biologic utilization.
4. Increasing Access to Dermatology Care
Teledermatology accelerates diagnosis and long-term disease management.
5. Growing Awareness of Systemic Psoriasis Burden
Governments and dermatology societies promote early intervention for moderate to severe cases.
Market Restraints
• High cost of biologics and targeted therapies
• Reimbursement challenges in developing regions
• Long-term immunosuppression risks
• Diagnostic delays in underserved populations
Market Opportunities
1. Next-Generation IL-23 Inhibitors
Longer dosing intervals and improved safety offer strong growth prospects.
2. Expansion of JAK Inhibitors
Short-term flare control and systemic inflammation reduction broaden their adoption.
3. Personalized Dermatology & Biomarkers
Pharmacogenomic testing and cytokine signatures will guide therapy selection.
4. AI-Based PASI Scoring Tools
Improves accuracy in severity assessment for telemedicine and clinic use.
5. Biosimilars for TNF and IL-17 Inhibitors
Creates affordability and increases biologic penetration globally.
Segmentation Overview
By Treatment Type
• Biologics
o IL-17 inhibitors
o IL-23 inhibitors
o TNF inhibitors
o IL-12/23 inhibitors
• Systemic therapies
• Oral targeted therapies (PDE4 & JAK inhibitors)
• Phototherapy
• Topical adjunct therapies
By Route of Administration
• Injectable (SC/IV)
• Oral
• Topical (supportive care)
By Patient Group
• Adults
• Adolescents
• Pediatric (emerging approvals)
By End User
• Hospitals
• Dermatology clinics
• Specialty infusion centers
• Retail & online pharmacies
Explore Full Report here: https://exactitudeconsultancy.com/reports/71343/moderate-to-severe-psoriasis-market
Regional Insights
North America - Largest Market
High biologic penetration, strong reimbursement coverage, and significant PsA comorbidity burden.
Europe - Widely Adopted Biologic Treatment Pathways
NICE/EADV guidelines drive structured use of advanced therapies.
Asia Pacific - Highest Growth Rate
Large population, urbanization, pollution, and rising healthcare access.
Latin America - Expanding Dermatology Care
Growing awareness and improving therapeutic access.
Middle East & Africa - Emerging
Infrastructure expansion supports gradual adoption.
Competitive Landscape
Key companies active in moderate to severe psoriasis therapy development include:
• Novartis
• Eli Lilly
• AbbVie
• Johnson & Johnson (Janssen)
• Amgen
• UCB Pharma
• Pfizer
• Bristol Myers Squibb
• Sun Pharma
• LEO Pharma
Focus areas: IL-17/IL-23 inhibition, next-generation biologics, JAK inhibitors, and topical innovation.
Recent Market Developments
• New IL-23 inhibitors showing multi-year sustained skin clearance
• Expansion of biologics into pediatric and adolescent populations
• Increased real-world data validating JAK inhibitor effectiveness
• Significant AI integration for remote PASI scoring
• Biosimilar launches improving biologic affordability
Future Outlook (2025-2034)
The Moderate to Severe Psoriasis Market will grow rapidly as:
• Biologics continue expanding globally
• Oral targeted therapies gain broader acceptance
• Precision medicine guides treatment pathways
• Digital dermatology improves triage and diagnosis
• New-generation IL-23 and IL-17 biologics reshape long-term care
By 2034, the market is forecasted to reach USD 47.68 billion, supported by strong innovation in immunology and rising treatment demand among high-severity patients.
This report is also available in the following languages : Japanese (中等度から重度の乾癬市場), Korean (중등도에서 중증 건선 시장), Chinese (中重度银屑病市场), French (Marché du psoriasis modéré à sévère), German (Markt für mittelschwere bis schwere Psoriasis), and Italian (Mercato della psoriasi da moderata a grave), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/71343
Our More Reports:
Moderate to Severe Plaque Psoriasis ( ONLY CANADA DATA) Market
https://exactitudeconsultancy.com/reports/71425/moderate-to-severe-plaque-psoriasis-only-canada-data-market
Phototherapies for Psoriasis Market
https://exactitudeconsultancy.com/reports/71430/phototherapies-for-psoriasis-market
Concussion Market
https://exactitudeconsultancy.com/reports/72676/concussion-market
Alzheimer's Disease Treatment Market
https://exactitudeconsultancy.com/reports/76109/alzheimer-s-disease-treatment-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Moderate to Severe Psoriasis Market is projected to reach USD 47.68 billion by 2034 here
News-ID: 4309554 • Views: …
More Releases from Exactitude Consultancy
Pancreatic Cancer Patient Pool Analysis Market Damand,Trades 2034
Market Overview
The Pancreatic Cancer Patient Pool Analysis Market is expanding as global incidence and mortality rates continue to rise, creating growing demand for accurate patient profiling to support treatment planning, clinical research, and healthcare resource allocation.
Pancreatic cancer is one of the most aggressive malignancies, often diagnosed at late stages due to limited early symptoms. As awareness improves and advanced diagnostics such as CT, MRI, endoscopic ultrasound, and biomarker testing become…
Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Market Demands 2025-2034
Market Overview
The Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Market is evolving as new therapeutic options increasingly shift treatment standards for one of the most aggressive lung cancer subtypes. ES-SCLC represents the majority of SCLC diagnoses and is characterized by rapid tumor growth, early metastasis, and high relapse rates.
Despite long-standing reliance on chemotherapy, recent advances in immunotherapy, targeted drugs, biomarker-driven approaches, and combination regimens are transforming patient outcomes. Growing awareness, improved…
Metastatic HER2-Positive Breast Cancer - Patient Pool Analysis Market Trades 203 …
Market Overview
The Metastatic HER2-Positive Breast Cancer Patient Pool Analysis Market is expanding as global incidence rates continue to rise and treatment advances improve survival outcomes. HER2-positive breast cancer accounts for a significant portion of metastatic breast cancer cases and is known for its aggressive progression.
With improvements in diagnostics, biomarker testing, and early screening programs, the number of identified HER2-positive cases is increasing worldwide. The emphasis on understanding patient population characteristics-such…
Moderate Psoriasis Market is projected to reach USD 16.21 billion by 2034
The global Moderate Psoriasis Market was valued at USD 7.94 billion in 2024 and is projected to reach USD 16.21 billion by 2034, growing at a CAGR of 7.5% during 2025-2034. Market expansion is driven by rising global psoriasis prevalence, increased diagnosis of moderate disease, rapid adoption of biologics and targeted small molecules, and growing awareness of early intervention to prevent disease progression and systemic complications.
Download Full PDF Sample Copy…
More Releases for Moderate
Synchronous Condenser Market Set for Moderate Growth by 2030
According to a new report published by Allied Market Research, The synchronous condenser market size was valued at $568.9 million in 2020, and is projected to reach $751 million by 2030, growing at a CAGR of 2.8% from 2021 to 2030.
Synchronous condenser is the device used to generate or absorb reactive power as per the need for stabilization of electric utilities. It is an alternative to capacitor bank to correct…
Tin Market Outlook: Moderate Growth Projected Through 2032
Tin Market size was valued at 282.52 Kilotonin 2024 and the total Tin revenue is expected to grow at a CAGR of 2.1% from 2025 to 2032, reaching nearly 333.63 Kiloton.
Tin Market Overview:
The tin market is witnessing consistent growth due to its critical applications across several industries. Tin is most commonly used in soldering, particularly within the electronics industry, which continues to expand with the rise of consumer electronics, renewable…
Biocides Market Forecast Shows Moderate but Consistent Growth
Biocides market is expected to reach US$ 16.07 Bn. in 2030 from US$ 12.30 Bn. in 2023, with a CAGR of 3.9% for the period 2024-2030.
Biocides Market Overview:
The biocides market is experiencing steady growth, driven by increasing demand across various industries such as water treatment, healthcare, agriculture, and consumer goods. Biocides, which are chemical or biological agents that control harmful organisms, play a crucial role in ensuring hygiene, preserving materials,…
Dutch Mendenhall to Moderate Athletes in Business Panel
Las Vegas, NV - July 9, 2024 - Dutch Mendenhall [https://www.linkedin.com/in/dutchmendenhall], the esteemed owner of Wentworth Golf Club [https://wentworthgolfclub.org/], best-selling author of Money Shackles, and former Division 1 volunteer coach, will moderate the "Athletes in Business" panel at The Palms Las Vegas on Sunday, July 14, 2024. This event will bring together some of the most influential athletes turned business professionals to share their insights and experiences.
Dutch Mendenhall's diverse background…
Planter Market will reflect a relatively moderate growth in demand
Planter is a container used for planting flowers, and different types of small plants. It can be of plastic, wood, ceramics, and glass. Planters are of different sizes, shapes, and colors. These are mostly used for decoration, nurseries, and greenhouses for both interior as well as exterior decoration. These help enhance the appearance of the property. The use of planter in decoration in hotels, rental houses can attract the customer.
…
Mild-to-Moderate Atopic Dermatitis Treatment Market: Lucrative Opportunities
Mild-to-moderate atopic dermatitis is a chronic inflammatory skin disease often localized to the flexural surfaces of the body and usually begins in childhood. This skin disease affects a large percentage of the world's population. Atopic dermatitis, commonly known as eczema, is characterized by dry skin, itching, redness, swelling, vesicle formation, cracking, weeping, crusting, and scaling. Atopic dermatitis is a long-term skin disease, which is classified into different types depending on…
